Medical board discipline for complementary, alternative & integrative medical therapies is a concern our attorneys address when physicians integrate CAM into their practices and clinics.
Disciplinary provisions for "unprofessional conduct" or "professional conduct" vary by state.
Here is one analysis, which we conducted for a client located in Georgia. Of course, a similar approach, tailored to New York, California, Massachusetts, Oregon, Vermont, or any other state, could be conducted:
The disciplinary provisions allow the GCMB to discipline a physician for conduct including when the physician has:
(6) Advertised for or solicited patients; obtained a fee or other thing of value on the representation that a manifestly incurable disease can be permanently cured; or made untruthful or improbable statements, or flamboyant or extravagant claims concerning his or her professional excellence or treatment protocols;
(7) Engaged in any unprofessional, unethical, deceptive, or deleterious conduct or practice harmful to the public, which conduct or practice need not have resulted in actual injury to any person. As used in this paragraph, the term "unprofessional conduct" shall include any departure from, or failure to conform to, the minimum standards of acceptable and prevailing medical practice and shall also include, but not be limited to, the prescribing or use of drugs, treatment, or diagnostic procedures which are detrimental to the patient as determined by the minimum standards of acceptable and prevailing medical practice or by rule of the board.
The language in (6) certainly cautions against exaggerating claims concerning the benefits of CAM therapies. It is a good practice to have counsel review your website and any major changes in website language and advertising that will discuss functional or CAM methods.
More generally, the broad language in (7) concerning “any departure” from “minimum standards of acceptable and prevailing medical practice” allow the Board at their discretion to investigate and potentially impose discipline for nonstandard practices, be they the different diagnostic and treatment reasoning contained in functional medicine or complementary or alternative methods such as computer-based GSR devices such as NES. The risk of such intervention by the Board is greatest when a CAM therapy is used in lieu of conventional care.
This has been a long-standing issue for physicians practicing CAM in other states with statutes containing similar language. Historically, the issue came to a head with In re Guess, a 1990 case decided by the North Carolina Supreme Court. Guess was an MD who used homeopathy as a last resort. The state medical board charged him with “unprofessional conduct” under a state statute defining the same as any departure from “standards of acceptable and prevailing medical practice in the state.” Even though patients testified at the medical board hearing that Guess had only helped them, and there was no evidence that he had ever harmed a patient, the Board revoked his licensed based on the statutory definition. After a trial and an appeal, the state Supreme Court upheld the revocation, noting that the statute allowed revocation without any showing of injury to a patient.
Georgia has an “Access to Medical Treatment Act.” This legislation provides:
(b) Notwithstanding any other provision of law, and except as provided in subsection (c) of this Code section, an individual shall have the right to be treated for any illness or disease which is potentially life threatening or chronically disabling by a person licensed to practice medicine under this article with any experimental or nonconventional medical treatment that such individual desires or the legal representative of such individual authorizes if such person licensed to practice medicine under this article has personally examined such individual and agrees to treat such individual.
(c) A person licensed to practice medicine under this article may provide any medical
treatment to an individual described in subsection (b) of this Code section if:
(1) There is no reasonable basis to conclude that the medical treatment itself, when administered as directed, poses an unreasonable and significant risk of danger to such individual; and
(2) The person licensed to practice medicine under this article has provided the patient with a written statement and an oral explanation, which the patient has acknowledged by the patient’s signature or the signature of the patient’s legal representative, that discloses the facts regarding the nature of the treatment, specifically including that the treatment offered is experimental or nonconventional, that the drug or medical device has not been approved by the Food and Drug Administration for any indication, as well as the material risks generally recognized by reasonably prudent physicians of such treatment’s side effects.
(d) The treatment of patients in compliance with this Code section by a person licensed to practice medicine under this article shall not by itself constitute unprofessional practice or conduct.
Note that the carve-out the Act provides for CAM is limited to treating a patient “for any illness or disease which is potentially life threatening or chronically disabling.” This is a much more limited carve-out than, as noted, some other states provide for physicians using CAM.
Although medical boards in other states with similar statutes have deployed the “any departure” language against physicians who have integrated CAM therapies, such a broadly worded provision—together with Georgia’s narrow statutory carve-out—certainly does not mean that including CAM will lead to discipline. The language does, however, suggest caution. As we discussed in our conference call, the use of nonstandard diagnostic tests such as saliva-based horomonal work-ups or narrower reference ranges when interpreting tests such as TSH for the diagnosis of hypothyroidism can raise standard of care issues when they cross into areas for which the Board is not willing to allow for professional differences of opinion.
Judging the risk of adopting functional or CAM practices is an uncertain enterprise that ideally includes researching what methods have resulted in discipline in Georgia in the past, how the medical community views the method, whether the method is supported by a national organization that is able to issue CMEs for training in the method, the extent to which the method supplants a conventional method that is seen as well-established, the risks of the functional or CAM method and respective risks with any competing conventional approach, and the regulatory posture of FDA when relevant.
It is important to recognize that disciplinary cases are fact bound and rarely arise as a simple charge that a “forbidden” therapy is being done. Cases almost always involve the details of how the therapy was practiced, the quality of the medical reasoning and decision making in a number of cases as well as the quality of the record keeping. Two physicians could incorporate a given CAM therapy into that practice and one never have any difficulty and the other be disciplined, because one may practice good medicine and use the therapy as as energetic adjunct while the other wanders into its use in clinical decision making.
With regard to the nonconventional nature of these therapies, however, in the context of malpractice defense, there is a legal defense to medical malpractice known as the “respectable minority” doctrine. The rule essentially states that a physician who undertakes a mode of treatment that a respectable minority within the profession would undertake under similar circumstances, does not incur liability for negligence merely because the physician substituted such an approach for the more generally approved one.
While one could argue that functional medicine has garnered such a respectable minority, this does not necessarily apply to the Board, which has significant leeway to set standards of care. In other words, “respectable minority” is a defense to a medical practice action, but in a disciplinary case, the medical board may or may not respect a standard of care deviation based on the existence of such a professional minority viewpoint. At the same time, however, that a functional approach at issue is taught at conferences sponsored by such respectable minority organizations, such as the American College for Advancement in Medicine or the Institute for Functional Medicine is useful. Collecting CME credits for functional approaches of interest is an important defensive consideration, as the granting of credits for course content that includes a questioned therapy is valuable evidence that at there is some recognition of the therapy.
O.C.G.A. § 43-34-8. The Board Rules contain still other rules governing physician practices. For example, physicians must post a declaration of the patient’s rights to file a grievance with the Board concerning a physician, staff, office or treatment received. Rule 350-27-.02 (See Appendix 1).
 North Carolina voters reacted to the decision, and in 1993, North Carolina enacted a “medical freedom” law, providing that the Board cannot revoke a physician’s license “solely” because the physician practices a therapy “that is experimental, nontraditional, or that departs from acceptable and prevailing medical practices,” unless the Board can establish that the treatment is either ineffective, or, more dangerous that the prevailing conventional therapy.
This kind of statute, replicated in various forms in other states, provides “medical freedom” (or at least expanded health care choices) to the patient by granting the physician some leeway to incorporate CAM therapies without that the medical board will initiate disciplinary proceedings “solely” because of including CAM. There were numerous efforts to bring similar bills into law on the federal level—notably through introduction in 1995 of the federal Access to Medical Treatment Act—but such efforts failed.
 O.C.G.A. § 43-34-38.
Healthcare & FDA attorney Michael H. Cohen is a thought leader in healthcare law & FDA law, pioneering legal strategies in healthcare. wellness, and lifestyle markets. As a corporate and transactional lawyer, FDA regulatory attorney who also handles healthcare litigation, healthcare mediation and healthcare arbitration, and international healthcare & wellness law speaker, Los Angeles / Bay Area healthcare & FDA lawyer Michael H. Cohen represents conscious business leaders in a transformational era. Clients seek healthcare & FDA attorney Michael H. Cohen’s legal savvy on all aspects of business law, healthcare law, and FDA law, including:
- business structure and entity formation (corporations, partnerships, LLCs)
- health care facility licensing issues (home health agency, hospice, imaging center)
- practitioner licensing matters;
- physician and allied & complementary medicine provider employment contracts and independent contractor agreements
- e-commerce (including online health education and mobile medical apps) legal
- copyright & trademark, licensing
- informed consent and liability risk management
- HIPAA and confidentiality and privacy issues
- Stark, self-referral, anti-kickback, patient brokering, and fee-splitting questions
- cosmetics claims, labeling
- OTC drug & homeopathics FDA legal review
- medical device FDA legal issues
- dietary supplement claims and labeling
- insurance reimbursement and Medicare issues for healthcare practitioners
- concierge medicine legal issues
- telemedicine legal, m-health, and digital health law
- business law and health care regulatory compliance arenas
- healthcare meditation and healthcare arbitration.
Whether advising start-ups or established companies, Los Angeles / San Francisco / Bay Area healthcare & FDA attorney Michael H. Cohen brings his entrepreneurial spirit and caring insight to cutting-edge legal and regulatory challenges. The Michael H. Cohen Law Group counsels healthcare practices, entities, and companies, such as clinical laboratories, physicians, psychologists, chiropractors, acupuncturists, naturopaths, nurses, healers, medical spas, sleep centers, addiction treatment centers, surgery centers, anti-aging centers, integrative medicine clinics, anti-aging practices, mental and behavioral health counselors, medical service organizations, telemedicine and mobile (m-health) companies, online health ventures, stem cell and cord blood entities; and other health and wellness enterprises. Healthcare and FDA lawyer Michael H. Cohen is admitted to practice in California, Massachusetts, New York, and Washington, D.C. Our clientele is national and international, and we also counsel healthcare and FDA clients in Los Angeles, San Diego, Ventura, San Francisco Bay Area, San Jose, Santa Barbara, Sacramento, San Bernadino, Alameda, Contra Costa County, and other California cities and counties. Contact our Los Angeles, Ventura County, & San Francisco Bay Area FDA & healthcare attorneys today if you need a telemedicine lawyer, concierge medicine lawyer, HIPAA lawyer, FDA lawyer or FDA regulatory consultant (dietary supplements, medical devices, cosmetics, OTC drugs), advertising compliance lawyer, healthcare mediator or arbitrator, concierge medicine attorney, management services organization attorney, or other specialized healthcare legal advice or FDA regulatory consulting.